The capacity for IRF-1 to promote apoptosis and inhibit autophagy in splenocytes was demonstrated within endotoxemia [8], and a relationship between IRF-1 and autophagy was also reported in tumor cells. Here, IRF1 is linked to serum lipopolysaccharide activity.